tbuckley/cabot-search huggingface dataset:
When Less Is More: Intravenous Immune Globulin for the Treatment of New-Onset Pediatric Immune Thrombocytopenia
Authors: Eyal Elron, Osama Tanous, Esti Shamba, Orna Steinberg Shemer, Tracie Goldberg, Shai Izraeli, Joanne Yacobovich, Oded Gilad
Journal: Blood (2022)
Suppression of Multiple Myeloma Via Inhibition of EFNB2 Reverse Signaling
Authors: Joshua P. Sasine, Jennifer Dukov, Dana Tran, Heather A Himburg, Natalia Kozlova, Michelle Li, Jenny Kan, Mary Sehl, Gary J. Schiller, Ritchie Ho, Brijesh Singh, Bryanna Reinhardt, Peibin Yue, Christina Termini, Elena Pasquale, John P. Chute
Journal: Blood (2022)
Characterization of the Human Mesenchymal Stromal Compartment in Normal Homeostasis and Acute Myeloid Leukemia at the Level of the Single Cell
Authors: Sara Ali, Syed Mian, William Grey, Manuel Garcia-Albornoz, Fatihah Mohamad Nor, Aneesh Sharma, Samantha Atkinson, Linda Ariza McNaughton, John G. Gribben, Dominique Bonnet
Journal: Blood (2022)
Premedication and Therapeutic Drug Monitoring (TDM) for Pegaspargase: A Prospective Multicenter Multi-Ethnic Study of Pediatric and Adolescent Patients
Authors: Van T Huynh, Sonia Morales, Anurag K. Agrawal, Christine L. Phillips, Keith J August, Erin Guest, Beth Apsel Winger, Catherine Aftandilian, Janel R. Long-Boyle, Kirsten Kasper, Keri Zabokrtsky, Carol Hwang Lin
Journal: Blood (2022)
Inter-Modality Variance of Blast Quantification in Patients with Myelodysplastic Syndrome (MDS) and Its Impact on Risk Stratification and Overall Survival
Authors: Laurenz Steiner, Navkirandeep Kaur, Alexander Streuer, Johann-Christoph Jann, Alice Fabarius, Georgia Metzgeroth, Wolf-Karsten Hofmann, Daniel Nowak, Mohamad Jawhar
Journal: Blood (2022)
Subgroup Analysis of Adverse Events Following Rusfertide Dosing in Revive: A Phase 2 Study of Patients with Polycythemia Vera
Authors: Naveen Pemmaraju, Srdan Verstovsek, Marina Kremyanskaya, Frank Valone, Nishit B. Modi, Sarita Khanna, Paula G. O'Connor, Suneel K. Gupta, Ronald Hoffman
Journal: Blood (2022)
Polycythemia Vera Patients with &amp;gt;20% Reduction in Whole Blood <i>JAK2V617F</i> Allele Frequency Have Improved Myelofibrosis-Free Survival but Not Overall Survival
Authors: Ghaith Abu-Zeinah, Franco Castillo Tokumori, Katie Erdos, Imane Bouhali, Daniel C Choi, Richard T. Silver, Joseph Scandura
Journal: Blood (2022)
Assessment of Midostaurin in Combination with Idarubicin-Based Induction Treatment in Acute Myeloid Leukemia
Authors: Julia Lee, Charlotte B Wagner, Stacy Prelewicz, Heena P Kurish, Rob Walchack, Danielle Cenin, Seema Patel, Mimi Lo, Danielle Schlafer, Belinda KT Li, R Donald Harvey, Bestis Wasef, Jian Ying, Tibor Kovacsovics
Journal: Blood (2022)
Total Costs of Care during Chimeric Antigen Receptor T-Cell Therapy in Patients with Relapsed/Refractory B Cell Non-Hodgkin Lymphoma: A Large Private Insurance Claim-Based Analysis
Authors: Mengyang Di, Jessica B Long, Iris Isufi, Francine M. Foss, Stuart Seropian, Cary P Gross, Scott F. Huntington
Journal: Blood (2022)
Survey of the Relevance of Quality of Life (QoL) Questionnaires (QoLQs) Currently Used to Evaluate Multiple Myeloma (MM) Patients' Qol in Real-World MM Patients and Healthcare Professionals (HCPs)
Authors: Sotirios Bristogiannis, Yadanar Lwin, Catherine SY Lecat, Joanne Sowter, Orla McCourt, Emma Dowling, Nuno Correia, Neil K Rabin, Ke Xu, Jonathan Sive, Xenofon Papanikolaou, Rakesh Popat, Lydia Lee, Annabel McMillan, Sosana Delimpasi, Ashutosh D. Wechalekar, Kwee Yong, Charalampia Kyriakou
Journal: Blood (2022)
More Than Ten Years Follow-up of Frontline Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia
Authors: Fadi Haddad, Koji Sasaki, Ghayas C. Issa, Kunhwa Kim, Jeffrey Skinner, Sara E Dellasala, Yesid Alvarado, Alessandra Ferrajoli, Tapan M. Kadia, Musa Yilmaz, Naveen Pemmaraju, Guillermo Garcia-Manero, Sherry A. Pierce, Elias Jabbour, Hagop Kantarjian
Journal: Blood (2022)
CD19 Expression by IHC Alone Is Not a Predictor of Response to Loncastuximab Tesirine: Results from the LOTIS-2 Clinical Trial and Quantitative Systems Pharmacology Modeling
Authors: Paolo F. Caimi, Mehdi Hamadani, Carmelo Carlo-Stella, Masoud Nickaeen, Eric Jordie, Kiersten Utsey, Tim Knab, Francesca Zammarchi, Serafino Pantano, Karin Havenith, Ying Wang, Joseph Boni
Journal: Blood (2022)
Copy Number Alterations of Chromosome 9p24.1 in Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received ABVD: An Ancillary Analysis of Multi-Center Retrospective Study in Japan (HORIZON study)
Authors: Shinichi Makita, Shigeru Kusumoto, Jun-Ichi Tamaru, Hiroya Hashimoto, Akiko Miyagi Maeshima, Toshiki Uchida, Hideki Tsujimura, Eiichi Ohtsuka, Nobuyuki Takayama, Kayoko Murayama, Naoki Takahashi, Masahiro Yoshida, Hiroaki Morimoto, Yasuhiro Suzuki, Kazuyuki Shimada, Masanori Makita, Shuichi Ota, Hiroshi Gomyo, Hiroyuki Takahashi, Ritsuro Suzuki, Hiroo Katsuya, Hiro Tatetsu, Shuji Momose, Takahisa Yamashita, Kumiko Ohsawa, Naoko Asano, Dai Maruyama, Motoko Yamaguchi, Hirokazu Nagai
Journal: Blood (2022)
Infectious Complications and Their Relationship with Mortality in Patients Newly Diagnosed with Multiple Myeloma
Authors: Juan Luis Luis Ontiveros, Sandra Rajme-López, Alfonso Orozco, Sergio Rodriguez-Rodriguez, Santiago Riviello-Goya, Alec Seidman-Sorsby, Alvaro Aguayo, Déborah Martínez-Baños
Journal: Blood (2022)
Health-Related Quality of Life and Financial Burden of Ethiopian Patients with Chronic Myeloid Leukemia Receiving Tyrosine Kinase Inhibitors
Authors: Fisihatsion Tadesse, Amha Gebremedhin, Abdulaziz Abubeker, Alfonso Piciocchi, Marta Cipriani, Lalise Gemechu, Atalay Mulu, Getahun Asres, Fabio Efficace
Journal: Blood (2022)
Adolescent and Young Adults with ALL Who Complete Therapy on DFCI Consortium ALL Trials Have Excellent Long-Term Overall Survival
Authors: Yannis K. Valtis, Yael Flamand, Shai Shimony, Andrew E. Place, Lewis B. Silverman, Lynda M. Vrooman, Andrew M. Brunner, Stephen E. Sallan, Martha Wadleigh, Richard M. Stone, Daniel J DeAngelo, Marlise R. Luskin
Journal: Blood (2022)
Identification of Molecular Mechanisms Governing CAR-T Cell Response in MM Patients Using Single Cell Transcriptomics
Authors: Lorea Jordana-Urriza, Guillermo Serrano, Maria Erendira Calleja-Cervantes, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Asier Ullate-Agote, Aintzane Zabaleta, Diego Alignani, Teresa Lozano, Valentin Cabañas, Almudena Navarro-Bailón, Aina Oliver-Caldes, Marta Español-Rego, Mariona Pascal, Manel Juan, Álvaro Urbano-Ispizua, Juan Luis Reguera, Jose Maria Moraleda, Maria-Victoria Mateos, Fermin Sanchez-Guijo, Ana Alfonso Pierola, José J. Rifón Roca, Paula Rodríguez-Otero, Carlos Fernandez de Larrea, Bruno Paiva, Susana Inogés, Ascensión López-Diaz de Cerio, Juan Jose Lasarte, Jesús San-Miguel, Juan Roberto Rodriguez-Madoz, Mikel Hernáez, Felipe Prósper
Journal: Blood (2022)
Limited Long-Term Benefit of Upfront Autologous Stem Cell Transplant on Survival in Severe Renal Impairment in Multiple Myeloma in Novel Drug Era, a Retrospective Multi-Center Study in China
Authors: Huixing Zhou, Yuan Jian, Weiwei Xie, Yuan Ren, Zhiyao Zhang, Guangzhong Yang, Chuanying Geng, Jing Jia, Wenming Chen, Jian Li, Wenrong Huang, Xinan Cen, Wen Gao
Journal: Blood (2022)
Intense Immunosuppressive Therapy (anti-thymocyte globulin, alemtuzumab) As Salvage Therapy in Refractory T-Cell Large Granular Lymphocytic Leukemia and Pure Red Cell Aplasia
Authors: Fauzia Ullah, Danai Dima, Carmelo Gurnari, Suresh Kumar Balasubramanian, Olisaemeka Ogbue, Hussein Awada, Naomi Kawashima, Najiullah Omar, Swapna Thota, Hetty E. Carraway, Valeria Visconte, Jaroslaw P. Maciejewski
Journal: Blood (2022)
Final Analysis of the Prospective Multicenter CLL2-Give Trial of Obinutuzumab (GA101, G), Ibrutinib (I), and Venetoclax (Ve) in Untreated Patients with CLL with 17p Deletion/<i>TP53</i> Mutation
Authors: Henriette Huber, Eugen Tausch, Christof Schneider, Simone Edenhofer, Julia Von Tresckow, Sandra Robrecht, Adam Giza, Can Zhang, Moritz Furstenau, Peter Dreger, Matthias Ritgen, Thomas Illmer, Anna Lena Illert, Jan Dürig, Sebastian Böttcher, Carsten Utoft Niemann, Michael Kneba, Anna-Maria Fink, Kirsten Fischer, Hartmut Döhner, Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer
Journal: Blood (2022)
<i>TP53</i> and Complex Karyotype Represent a Very High-Risk Group in Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation: An International Collaborative Analysis
Authors: Nico Gagelmann, Anita Badbaran, Rachel Beth Salit, Thomas Schroeder, Carmelo Gurnari, Simona Pagliuca, Arnold Ganser, Christina Rautenberg, Bruno Cassinat, Felicitas R Thol, Christine Wolschke, Marie Robin, Michael Heuser, Marie Thérèse Rubio, Jaroslaw P. Maciejewski, Hans Christian Reinhardt, Bart L. Scott, Nicolaus Kroeger
Journal: Blood (2022)
Primary Results of Stimulus-MDS1: A Randomized, Double-Blind, Placebo-Controlled Phase II Study of TIM-3 Inhibition with Sabatolimab Added to Hypomethylating Agents (HMAs) in Adult Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
Authors: Amer M. Zeidan, Kiyoshi Ando, Odile Rauzy, Mehmet Turgut, Ming-Chung Wang, Roberto Cairoli, Hsin-An Hou, Yok-Lam Kwong, Montserrat Arnan Sangerman, Stef Meers, Vinod A. Pullarkat, Valeria Santini, Kamel Malek, Flavia Kiertsman, Jiaying Lyu, Pedro Marques Ramos, Pierre Fenaux, Yasushi Miyazaki, Uwe Platzbecker
Journal: Blood (2022)
Mantle Cell Lymphoma in Brazil: First Report from a Real-World Evidence Study of a Third World Country
Authors: Lara Gallucci Figorelle, Fernanda Oliveira, Renata Lyrio, Flávia Dias Xavier, Mariana Guarana, Bruna Souza Sabioni, Celso Arrais-Rodrigues, Noemi Da Silva Lira, Peterson Tiago Galvao, Cristiane Milito, Katia Carneiro, Valeria Vianna, Rony Schaffel
Journal: Blood (2022)
A Descriptive Analysis of <i>TP53</i> Y220C Mutations in Patients with Hematologic Malignancies
Authors: Georgina Gener-Ricos, Koji Sasaki, Sanam Loghavi, Abhishek Maiti, Nicholas Short, Fadi Haddad, Naval Daver, Gautam Borthakur, Farhad Ravandi, Hagop Kantarjian, Keyur P. Patel, Michael Andreeff, Courtney D. DiNardo
Journal: Blood (2022)
A Multi-Center Study: Outcomes Among Relapsed/Refractory Diffuse Large B Cell Lymphoma Patients with CD20 Loss
Authors: Radhika Takiar, Wern Lynn Ng, Eshana Shah, Philip S. Boonstra, Yasmin H. Karimi, Shannon A. Carty, Ryan A. Wilcox, Carlos A. Murga Zamalloa, Grzegorz S. Nowakowski, Tycel J. Phillips
Journal: Blood (2022)
<i>Cutaneous/ Subcutaneous Involvement - an Immune</i> <i>privileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma.</i>
Authors: Ranjit Nair, Rishab Prakash, Anna Dang, Jillian R. Gunther, Auris Huen, Jie Xu, Luis Enrique Malpica Castillo, Carlos Torres Cabala, Meghan Heberton, Penny Fang, Sairah Ahmed, Roberto N. Miranda, Luis Fayad, Raphael Steiner, Hun Ju Lee, Dai Chihara, Preetesh Jain, Samer A Srour, Jeremy L Ramdial, Yago Nieto, Loretta J. Nastoupil, Chelsea C. Pinnix, Sattva S. Neelapu, Christopher R. Flowers, L. Jeffrey Medeiros, Chitra Hosing, Michael L. Wang, Bouthaina S. Dabaja, Francisco Vega, Lei Feng, Swaminathan Padmanabhan Iyer
Journal: Blood (2022)
Fludarabine, Cyclophosphamide and Rituximab (FCR) As First Line Treatment in Patients with Chronic Lymphocytic Leukemia (CLL): A Long-Term Analysis of the German CLL Study Group (GCLLSG) Registry
Authors: Nadine Kutsch, Anna Maria Fink, Anno Federhen, Adam Giza, Sandra Robrecht, Janina Stumpf, Andrea Stoltefuß, Ursula Vehling-Kaiser, Michael Koenigsmann, Eugen Tausch, Christof Schneider, Stephan Stilgenbauer, Thomas Illmer, Rudolf Schlag, Steffen Dörfel, Tobias Gaska, Michael G. Kiehl, Kirsten Fischer, Barbara Eichhorst, Michael Hallek
Journal: Blood (2022)
Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-Cell Lymphomas Treated with Chimeric Antigen Receptor T-Cell (CART) Therapy
Authors: Reem Karmali, Narendranath Epperla, Geoffrey Shouse, Jason T. Romancik, Tamara K. Moyo, Vaishalee P. Kenkre, Thomas A. Ollila, Lindsey A. Fitzgerald, Brian T. Hess, Andrew M. Evens, Ishan Roy, Joanna Zurko, Sayan Mullick Chowdhury, Kaitlin Annunzio, Robert Ferdman, Rahul Bhansali, Elyse I. Harris, McKenzie Sorrell, Jieqi Liu, Imran A. Nizamuddin, Shuo Ma, Jonathan Moreira, Jane N. Winter, Barbara Pro, Deborah M. Stephens, Alexey V Danilov, Nirav N. Shah, Jonathon B. Cohen, Stefan K. Barta, Pallawi Torka, Leo I. Gordon
Journal: Blood (2022)
A Methodologically Updated De-Novo Extraction of Copy Number Signatures in Multiple Myeloma: Clinical Significance and Putative Aetiologies
Authors: Andrea Poletti, Stafano Delle Vedove, Gaia Mazzocchetti, Vincenza Solli, Ajsi Kanapari, Enrica Borsi, Marina Martello, Giovanni Martinelli, Silvia Armuzzi, Ilaria Vigliotta, Barbara Taurisano, Ignazia Pistis, Elena Zamagni, Michele Cavo, Carolina Terragna
Journal: Blood (2022)
ALLG AMLM26 Phase 1B/2 Study Investigating Novel Therapies to Target Early Relapse and Clonal Evolution As Pre-Emptive Therapy in AML (INTERCEPT): A Multi-Arm, Precision-Based, Recursive, Platform Trial
Authors: Andrew H Wei, Harry J Iland, John Reynolds, Sun Loo, Chong Chyn Chua, David Westerman, Ing S Tiong, Adam Ivey, Piers Blombery, Natasha S Anstee, Rachel M Koldej, David J. Curtis, David Kipp, David Ritchie, David M Ross, Amanda Souza, Jenny Collins, Ashish Bajel, Carolyn Grove, Paula Marlton, Andrew W Roberts, Naveen Pemmaraju, Keyur P. Patel, Sanam Loghavi, Marina Konopleva, Naval Daver, Courtney D. DiNardo
Journal: Blood (2022)
Impact of Extranodal Disease Involvement on Outcomes in Post-Transplant Lymphoproliferative Disorder
Authors: Megan Melody, Frederique St. Pierre, Irene Helenowski, William B Pearse, Chetan V Vakkalagadda, Joseph R. Leventhal, John Friedewald, Bing Ho, Daniel Ganger, Jane N. Winter, Leo I. Gordon, Adam Yuh Lin, Reem Karmali, Shuo Ma, Barbara Pro, Jonathan Moreira
Journal: Blood (2022)
Targeting Thrombophilia in Sickle Cell Disease with Isoquercetin: Results of a Fixed Dose, Single Center, Phase II Randomized Clinical Trial
Authors: Maria A. Lizarralde-Iragorri, Bindu Parachalil Gopalan, Brenda Merriweather, Jennifer Brooks, Mai Hill, Anna Conrey, Ruth Pierre Charles, Eveline Gwaabe, Neal Jeffries, Arun S. Shet
Journal: Blood (2022)
Splicing Analysis Unveils Convergent Transcriptomic Pathways in <i>U2AF1</i> S34 and Q157 Mutant Myeloid Neoplasia
Authors: Carmelo Gurnari, Arda Durmaz, Hussein Awada, Olisaemeka Ogbue, Yasuo Kubota, Tariq Kewan, Waled Bahaj, Chao-Yie Yang, Jacob Scott, Torsten Haferlach, Jaroslaw P. Maciejewski, Valeria Visconte
Journal: Blood (2022)
Should Adolescents and Young Adults with Hodgkin Lymphoma be Treated As Children or Adults?
Authors: Lucille Lew-Derivry, Pauline Brice, Camille Bigenwald, Judith Landman-Parker, Thierry Leblanc, Florian Chevillon, Nicolas Boissel, Aurélie Cabannes-Hamy
Journal: Blood (2022)
Prognostic Impact of Persistent Measurable Residual Disease in Patients with Acute Myeloid Leukemia FLT3+ Treated with Intensive Chemotherapy Plus Midostaurin - a Retrospective Study of the Polish Adult Leukemia Group (PALG)
Authors: Elzbieta Patkowska, Alicja Sadowska-Klasa, Jan Zaucha, Andrzej Szczepaniak, Lidia Gil, Lukasz Bolkun, Michal Gorka, Marta Antonina Libura, Renata Guzicka-Kazimierczak, Marta Anna Sobas, Anna Koclega, Jolanta Wozniak, Krzysztof Lewandowski, Iwona Solarska, Magdalena Wojtas, Aleksandra Leszczynska, Zuzanna Kandula, Edyta Subocz, Edyta Cichocka, Katarzyna Krawczyk, Dorota Hawrylecka, Agnieszka Pluta, Agnieszka Wierzbowska, Sebastian Giebel, Ewa Lech-Marańda
Journal: Blood (2022)
Interim Report of Bendamustine Plus Rituximab As First-Line Induction Therapy with or without Lenalidomide Maintenance Therapy in Chinese Patients with Indolent Non-Hodgkin's Lymphoma or Elderly Mantle Cell Lymphoma: Data from a Multi-Center Prospective Trial
Authors: Hui Wang, Qiang He, Rongrong Zhao, Linna Xie, Ji Ma, Cong Liu, Ke Lu, Haichen Wei, Dan Liu, Lijie Xing, Xiuzhi Deng, Zhongliang Sun, Xiaoxia Chu, Na Gao, Yuping Zhong, Yanhua Sun, Haiyan Zhang, Hao Zhang, Wenwei Xu, Zengjun Li
Journal: Blood (2022)
G-CSF Administration Is Associated with Worse Treatment Response and Survival after CAR T-Cell Therapy
Authors: Poorva Bindal, Pavania Elavalakanar, Caitlin A. Trottier, Laura E. Dodge, Emma K. Logan, David J. Sermer, Michael Leukam, Matthew J Weinstock, Robin M. Joyce, Jessica Liegel, Jacalyn Rosenblatt, David Avigan, Carolyn D. Alonso, Jon E. Arnason
Journal: Blood (2022)
A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma
Authors: Peter M. Voorhees, Anita D'Souza, Katja Weisel, David Duane Hurd, Raphael Teipel, Alfred Chung, Cesar Rodriguez, Sascha A. Tuchman, Neha Korde, Hana Safah, Orlando F. Bueno, Neil Pumford, Tanya S Rosenberg, Rajvineeth Kumar Pothacamury, Jeremy A. Ross, Akshanth R. Polepally, Shane Lee, Ziyi Jin, Chetasi Talati, Ravi Vij, Shaji K Kumar
Journal: Blood (2022)
The Value of PET/CT Combined with Next-Generation Flowcytometry in Minimal Residual Disease Detection and Prognostic Evaluation of Multiple Myeloma
Authors: Jianhua Du, Miao Chen, Li Huo, Wenjia Zhu, Huijuan Wang, Yun Leng, Shuangjiao Liu, Junling Zhuang
Journal: Blood (2022)
Characteristics and Outcomes of Patients with <i>BCOR</i> Mutated Myeloid Neoplasms
Authors: Anmol Baranwal, Mithun V. Shah, Amit Barua, Aysun Senturk Yikilmaz, Rong He, David S. Viswanatha, Talha Badar, Bahga Katamesh, Abhishek A. Mangaonkar, Naseema Gangat, Mrinal M. Patnaik, Mark R. Litzow, William J. Hogan, Kebede Begna, Ayalew Tefferi, Aref Al-Kali, Hassan B. Alkhateeb
Journal: Blood (2022)
Exploring the Effects of G-CSF Mobilization on the Immune Function of Mucosal-Associated Invariant T Cell Subsets By Single-Cell RNA-Seq
Authors: Gao Mengge, Jun Kong, Yuqian Sun, Zhidong Wang, Ting-Ting Han, Meng Lyu, Yu Wang, Xiaosu Zhao, Xiao Jun Huang
Journal: Blood (2022)
Persistence of Monoclonal Gammopathies in Serial Samples from a US Population-Based Screening Study
Authors: Habib El-Khoury, Luca Bertamini, Jean-Baptiste Alberge, David J. Lee, Ciara Murphy, Grace Fleming, Christian J. Cea-Curry, Maya I. Davis, Jacqueline Perry, Elizabeth D. Lightbody, Dhananjay Sakrikar, Derek Troske, David Barnidge, Mark C. Perkins, Stephen Harding, Gad Getz, Catherine R. Marinac, Irene Ghobrial
Journal: Blood (2022)
Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in <i>RUNX1</i>, <i>GATA2</i> and <i>DDX41</i>
Authors: Anna L. Brown, Claire Homan, Michael W. Drazer, Kai Yu, David Lawrence, Jinghua Feng, Luis Arriola-Martinez, Matthew Pozsgai, Kelsey McNeely, Thuong Ha, Parvathy Venugopal, Peer Arts, Sarah King-Smith, Jesse JC Cheah, Mark Armstrong, Csaba Bödör, Paul Wang, Alan B. Cantor, Mario Cazzola, Erin Degelman, Courtney D. DiNardo, Nicolas Duployez, Remi Favier, Stefan Fröhling, Ana Rio-Machin, Jeffery M. Klco, Alwin Krämer, Mineo Kurokawa, Joanne Lee, Luca Malcovati, Neil V Morgan, Georges Natsoulis, Carolyn Owen, Keyur P. Patel, Claude Preudhomme, Hana Raslova, Hugh Young Rienhoff, Tim Ripperger, Rachael Schulte, Kiran Tawana, Elvira Deolinda Rodrigues Pereira Velloso, Benedict Yan, Raman Sood, Amy Hsu, Steven M. Holland, Kerry Phillips, Nicola Poplawski, Milena Babic, Erika M Kwon Kim, Andrew H. Wei, Cecily Forsyth, Helen Mar Fan, Ian D Lewis, Julian Cooney, Rachel Susman, Lucy C Fox, Piers Blombery, Deepak Singhal, Devendra Hiwase, Andreas W Schreiber, Christopher N Hahn, Hamish S Scott, Paul P. Liu, Lucy A. Godley
Journal: Blood (2022)
The Novel Bispecific Innate Cell Engager (ICE®) AFM28 Efficiently Directs Allogeneic NK Cells to CD123+ Leukemic Stem- and Progenitor Cells in AML
Authors: Nanni Schmitt, Jana-Julia Siegler, Lena Wagner, Nicole Schulze, Alexandra Beck, Wolf-Karsten Hofmann, Torsten Haneke, Uwe Reusch, José Medina-Echeverz, Jan Endell, Thorsten Ross, Christian Merz, Daniel Nowak
Journal: Blood (2022)
Outcomes of Therapies and Resistance Mutations Following Non-Covalent Bruton's Tyrosine Kinase Inhibitor Treatment for Patients with Chronic Lymphocytic Leukemia and Richter Transformation
Authors: Meghan C. Thompson, Catherine C. Coombs, Lindsey E. Roeker, Jeffrey L. Jensen, Nirav N. Shah, Thomas Luo, Krish Patel, Neil Bailey, Bita Fakhri, Toby A. Eyre, Paola Ghione, Joanna M. Rhodes, Andrew D. Zelenetz, Justin Taylor, Maria Lia Palomba, Kendall Meyer, Danielle Rao, Yehudit Fox, Julia H. Aronson, Sarah Court, Omar Abdel-Wahab, Anthony R. Mato
Journal: Blood (2022)
Acute Myeloid Leukemia with Isolated Trisomy 4 Is Characterized By Frequent Mutations of <i>TET2</i> and a Distinct DNA Methylation Signature
Authors: Sayantanee Dutta, Paul Kerbs, Maja Rothenberg-Thurley, Bianka Ksienzyk, Stefan Krebs, Helmut Blum, Karsten Spiekermann, Klaus H. Metzeler, Tobias Herold, Sebastian Vosberg, Philipp A. Greif
Journal: Blood (2022)
Fibroblastic Stromal Cells Expressing Delta-like Notch Ligands Control Extrathymic T Cell Development in Mesenteric Lymph Nodes
Authors: Ashley Vanderbeck, Samantha Kelly, Leolene Carrington, Eric Perkey, Anneka Allman, Frederick Allen, Joshua D Brandstadter, Burkhard Ludewig, Chris Siebel
Journal: Blood (2022)
Comparing the Impact of NHEJ-CRISPR/Cas9 and Base Gene Editing on Rhesus Macaque Hematopoietic Stem Cell Clonal Behavior and Integrity
Authors: Diana M. Abraham, Yifan Zhou, Richard Lozano, Gregory A. Newby, David R. Liu, Chuanfeng Wu, Cynthia E. Dunbar
Journal: Blood (2022)
Phase 1/2 Study of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Results with &amp;gt;4 Years of Follow-up
Authors: Richard R. Furman, William G. Wierda, Anna Schuh, Piers EM Patten, Jorge M. Chaves, Jennifer R. Brown, Talha Munir, Peter Martin, Farrukh T. Awan, Deborah M. Stephens, Paolo Ghia, Jacqueline C. Barrientos, Krish Patel, Jennifer A. Woyach, Anna Butturini, Marianne de Borja, Min Hui Wang, Susan O'Brien, John C. Byrd
Journal: Blood (2022)
The N-Terminal Amino Acid Mutation Site Is a Potential Biological Marker for Precise Risk Stratification in Pediatric Patients with CEBPA-Dm AML
Authors: Shengqin Cheng, Yixin Hu, Li Gao, Liyan Fan, Yi Wang, Hailong He, Jie Li, Jun Lu, Peifang Xiao, Shaoyan Hu
Journal: Blood (2022)
Efficacy of Interventions to Build Transition Readiness for Youth with Sickle Cell Disease: A 13-Year Evaluation of a Healthcare Transition Program
Authors: Melissa Azul, Tarun D Aurora, Shiela Anderson, Andrew M Heitzer, Jennifer Longoria, Martha Barton, Yunusa Olufadi, Guolian Kang, Ana Baumann, Jerlym S. Porter, Jane Hankins
Journal: Blood (2022)
Interim Phase I Clinical Data of FT576 As Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma
Authors: Binod Dhakal, Jesus G. Berdeja, Tara Gregory, Thomas Ly, Cara Bickers, Xingyue Zong, Lilly Wong, Jode P. Goodridge, Sarah Cooley, Bahram Valamehr, Yu-Waye Chu, John Byon, Rafat Abonour
Journal: Blood (2022)
Allogeneic Hematopoietic Stem Cell Transplantation in Older Patients with Acute Myeloid Leukemia: Analysis of Outcomes and Contemporary Trends Spanning 10 Years
Authors: Alexandre Bazinet, Hagop Kantarjian, Naszrin Arani, Uday R. Popat, Courtney D. DiNardo, Naval Daver, Musa Yilmaz, Hussein A. Abbas, Nicholas Short, Ghayas C. Issa, Elias Jabbour, Sherry A. Pierce, Julianne Chen, Ricky Garcia, Marina Konopleva, Guillermo Garcia-Manero, Amin M. Alousi, Elizabeth J. Shpall, Richard E. Champlin, Gautam Borthakur, Farhad Ravandi, Tapan M. Kadia
Journal: Blood (2022)
Processing Speed Improvement in Hematologic Cancer Survivors Treated with Allogeneic Blood or Marrow Transplantation- a Randomized Online Cognitive Training Intervention
Authors: Noha Sharafeldin, Donna Murdaugh, Andie Grimm, Sylvia Cartagena, Victoria Seghatol-Eslami, Nora Balas, Liton F. Francisco, Lindsey Hageman, Joshua Richman, Smita Bhatia
Journal: Blood (2022)
Use of Ibrutinib in Real Life Settings in France: Results from a Retrospective Observational Study Using the Snds Database (OSIRIS)
Authors: Sylvain Choquet, Marine Deslandes, Nahid Macher, Gérard De Pouvourville, Clarisse Marchal, Manon Belhassen, Flore Jacoud, Vincent Levy
Journal: Blood (2022)